NAS:CLVS (USA)   Healthcare » Biotechnology
Clovis Oncology Inc logo

Clovis Oncology Inc $ 5.64 -0.03 (-0.53%)

Volume:
4,510,092
Avg Vol (1m):
13,019,909
Market Cap $:
589.75 Mil
Enterprise Value $:
996.45 Mil
PE Ratio:
0.00
PB Ratio:
0.00
Warning! GuruFocus has detected 5 Severe warning signs with CLVS. Click here to check it out.
Also Trade In: Germany UK
5D 3M YTD 1Y 5Y 10Y All 10Y (-%)

Clovis Oncology Inc News and Headlines -

GuruFocus Articles Total 7
  • 1

The stock of Clovis Oncology (NAS:CLVS, 30-year Financials) appears to be possible value trap, according to GuruFocus Value calculation. GuruFocus Value is GuruFocus' estimate of the fair value at which the stock should be traded. It is calculated based on the historical multiples that the stock has traded at, the past business growth and analyst estimates of future business performance. If the price of a stock is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line,

0 Views    GF Value    2021-04-18 09:12
S&P 500 gains 0.13%

The Dow Jones Industrial Average closed at 30,409.56 on Wednesday with a gain of 73.89 points or 0.24%. The S&P 500 closed at 3,732.04 for a gain of 5.00 points or 0.13%. The Nasdaq Composite closed at 12,870.00 for a gain of 19.78 points or 0.15%. The VIX Volatility Index was lower at 22.77 for a loss of 0.31 points or -1.34%.

Wednesday's Market Movers

U.S. stocks ended mostly higher Wednesday. The Treasury reported that they began dispensing $600 stimulus checks on Tuesday evening, with the expectations of all deposits and checks sent by mid-January.

In other news:

    103 Views    Julie Young    2020-12-31 15:06
    Cancer company has lost more than 90% of its market value in past five years

    Clovis Oncology Inc. (CLVS) CEO Patrick Mahaffy has made it clear he wants to sell the Boulder, Colorado-based biotech, which focuses on developing cancer drugs. So far, nobody’s come knocking.

    That no buyers have stepped up must rankle shareholders, who have seen their investment in the company drop more than 90% in the past five years. Adding to the misery, investors face share dilution, as Clovis is one of eight biotechs going to the secondary markets to raise sorely need cash. he company is planning to sell more than 11 million shares, hoping to raise $85 million.

    There’s

    258 Views    Barry Cohen    2020-05-21 17:24
    Company has been aiming for FDA approval for its lung cancer drug

    During the first quarter guru Kyle Bass (Trades, Portfolio) purchased 100,000 shares of Clovis Oncology Inc. (CLVS).

    Clovis Oncology is a biopharmaceutical company that is headquartered in Boulder, Colorado. The company focuses on acquiring, developing and commercializing cancer treatments in the U.S., Europe and other international markets. The company's development programs are targeted at specific subsets of cancer, combining personalized medicine with companion diagnostics to direct therapeutics to those patients who are the most likely to benefit from them.

    Clovis Oncology has a market cap of $594.22 million, an enterprise value of $428.92

    1718 Views    Kyle Ferguson    2016-05-25 16:09

    By Sarah Roden

    Following the annual J.P. Morgan Biotech Napa Forum, analyst Cory Kasimov offered commentary on a handful on biotechnology stocks. From a macro point of view, Kasimov found that other investors’ presentations at the forum were “quite constructive and focused on specific ideas” despite recent volatility in the sector. Although the media continues to highlight the biotech “bubble,” the consensus of the analysts “seemed to be that the notion is generally misplaced.” Here are the primary takeaways Kasimov offered on his top three near-term ideas:

    Bluebird bio Inc (BLUE):

    As one of Kasimov’s three top

    1256 Views    TipRanks    2015-04-14 19:01

    https://s3.amazonaws.com/gurufocus_userupload/03May20171130231493829023.jpgVBI Vaccines Inc. (VBIV)

    Shares of VBI Vaccines Inc. (VBIV)Â soared more than 20% in after-hours trading on Monday, following the announcement that Sanofi Pasteur has chosen VBIV's LPV(TM) (Lipid Particle Vaccine) formulation technology and expertise to reformulate a Sanofi Pasteur vaccine candidate to provide improved stability.

    As part of the collaboration agreement, Sanofi Pasteur has the option to acquire certain worldwide rights to use VBIV's LPV(TM) technology in its vaccines. The vaccine candidate and the terms of the agreement were not disclosed.

    https://s3.amazonaws.com/gurufocus_userupload/03May20171130231493829023.png

    VBIV is a biopharmaceutical company developing novel technologies that seek

    1006 Views    riddock57    2015-04-07 14:55

    Headlines Total 64
    • 1

    2021-05-05 $ 5.86 (6.35%)
    8:15am
    2021-04-28 $ 6.15 (%)
    11:33am
    2021-04-18
    4:12am
    2021-04-16 $ 5.98 (-1.97%)
    2:02am
    2021-04-13 $ 6.14 (-0.32%)
    3:59am
    2021-03-25 $ 6.61 (2.16%)
    10:30am
    2021-03-22 $ 7.47 (-4.96%)
    7:34am
    6:17am
    2021-03-19 $ 7.86 (47.74%)
    4:30pm
    2021-02-23 $ 6.01 (-10.03%)
    2:25pm
    9:47am
    2021-02-02 $ 8.17 (-3.43%)
    9:00am
    2021-02-01
    6:32pm
    2021-01-29 $ 7.9 (-6.06%)
    11:21am
    2020-12-30 $ 4.92 (10.56%)
    5:49am
    2020-12-22 $ 5.02 (-4.29%)
    9:28am
    9:05am
    2020-12-10 $ 4.805 (-1.74%)
    7:55am
    2020-12-05
    10:32am
    2020-11-09 $ 4.17 (-2.11%)
    1:30pm
    2020-11-06 $ 4.26 (-4.7%)
    2:16pm
    9:43am
    7:41pm
    2020-11-05 $ 4.47 (-21.16%)
    8:25am
    2020-10-29 $ 5.15 (-0.96%)
    11:35am
    2020-09-22 $ 6.96 (-1.56%)
    5:36pm
    2020-09-21 $ 7.07 (1.51%)
    10:53am
    2020-09-08 $ 5.18 (0.58%)
    7:53am
    2020-09-05
    10:31am
    2020-08-18 $ 5.89 (1.73%)
    11:52am
    2020-08-07 $ 5.42 (-13%)
    10:44am
    2020-08-06 $ 6.23 (-3.63%)
    6:10pm
    2020-07-30 $ 6.14 (0.82%)
    11:33am
    2020-07-21 $ 6.26 (-2.49%)
    11:00am
    2020-06-23 $ 7.47 (2.47%)
    7:37am
    2020-06-11 $ 6.59 (-7.7%)
    9:49am
    2020-06-04 $ 6.48 (-2.99%)
    10:31am
    2020-05-29 $ 6.92 (-1.84%)
    1:22pm
    1:13pm
    2020-05-21 $ 7.53 (0.4%)
    12:24pm
    3:22am
    2020-05-19 $ 7.52 (-16.07%)
    1:05pm
    2020-05-18 $ 8.96 (-7.53%)
    10:45am
    2020-05-16
    11:31am
    2020-05-14 $ 9.5 (3.37%)
    9:18am
    2020-05-11 $ 9.24 (2.44%)
    11:00am
    2020-05-07 $ 8.62 (6.82%)
    10:11am
    2020-05-06 $ 8.07 (4.67%)
    10:17am
    11:16pm
    2020-05-05 $ 7.71 (-4.16%)
    6:05pm
    2020-04-28 $ 7.99 (-2.2%)
    11:34am
    2020-04-27 $ 8.17 (-9.52%)
    1:17pm
    2020-04-22 $ 9.17 (-0.11%)
    8:00am
    2020-04-21 $ 9.18 (-2.34%)
    9:25am
    2020-04-20 $ 9.4 (15.2%)
    6:00pm
    2020-04-15 $ 7.21 (1.41%)
    11:00am
    2020-04-03 $ 6.1 (0.49%)
    4:50pm
    2020-03-26 $ 5.4 (21.9%)
    5:59pm
    2020-03-25 $ 4.43 (-5.14%)
    10:30am
    2019-03-06 $ 27.48 (-5.31%)
    7:03am
    2018-11-12 $ 14.48 (-7.48%)
    7:01am
    2018-10-18 $ 29.96 (-4.74%)
    11:06am
    2016-05-25 $ 16 (2.7%)
    11:09am
    2015-11-27 $ 32.22 (10.49%)
    8:14am
    Total 64
    • 1